• Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
  • Facebook
  • Twitter
The Wall Street Analyzer

  • Featured Interviews
  • CEO Interviews
  • News Feed
  • Spotlight
  • Sectors
    • Biotech
    • Cannabis
    • Consumer
    • Energy
    • Healthcare
    • Market News
    • Technology
Latest News
  • [ February 2, 2023 ] XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease News Feed
  • [ January 31, 2023 ] Zerify Starts The Year Off Strong News Feed
  • [ January 26, 2023 ] SCOTTIE RESOURCES INTERCEPTS 34.5 G/T GOLD OVER 4.7 METRES ON BLUEBERRY CONTACT ZONE News Feed
  • [ January 24, 2023 ] Zomedica to Participate in the Lytham Partners Investor Select Conference News Feed
  • [ January 23, 2023 ] XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial News Feed
  • [ January 18, 2023 ] Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies News Feed
  • [ January 17, 2023 ] SCOTTIE RESOURCES ANNOUNCES BOARD APPOINTMENT OF ELLIE OWENS News Feed
Home2023

Year: 2023

Video

Two market watchers discuss big tech, equity allocation, and the outlook for interest rates

February 3, 2023 The Wall Street Analyzer 0
World News

Asian shares jump, dollar eases after Powell comments

February 2, 2023 The Wall Street Analyzer 0

https://finance.yahoo.com/news/asian-shares-jump-dollar-eases-022705691.html

Market News

Eli Lilly Stock Slips as Hyped-Up Obesity Drug Sales Fall Short. Earnings Crush Estimates.

February 2, 2023 The Wall Street Analyzer 0

https://finance.yahoo.com/m/cee9238f-4f2a-32c2-b683-406907e55bdb/eli-lilly-stock-slips-as.html

Consumer

Fed’s interest-rate hikes make T-bills an attractive, safer investment

February 2, 2023 The Wall Street Analyzer 0

https://finance.yahoo.com/news/feds-interest-rate-hikes-make-t-bills-an-attractive-safer-investment-221957707.html

News Feed

XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease

February 2, 2023 The Wall Street Analyzer 0

CALGARY, Alberta, Feb. 01, 2023 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat […]

CEO Interviews

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF)

February 1, 2023 The Wall Street Analyzer 0
News Feed

Zerify Starts The Year Off Strong

January 31, 2023 The Wall Street Analyzer 0

EDISON, N.J., Jan. 31, 2023 (GLOBE NEWSWIRE) — Zerify Inc., (OTC Pink Sheets: ZRFY), the 21-year-old cybersecurity company focused on secure video conferencing & endpoint security, announced today that it’s having its strongest January since […]

CEO Interviews

FingerMotion (NASDAQ: FNGR)

January 31, 2023 The Wall Street Analyzer 0
Consumer

McDonald’s earnings haven’t been hit by higher prices, as ‘it just seems like Americans are more upset by the change in price at grocery stores’

January 30, 2023 The Wall Street Analyzer 0

https://www.marketwatch.com/story/mcdonalds-earnings-havent-been-hit-by-higher-prices-as-it-just-seems-like-americans-are-more-upset-by-the-change-in-price-at-grocery-stores-11675020046?siteid=yhoof2

World News

Oil settles lower ahead of expected rate hikes, OPEC committee meeting

January 30, 2023 The Wall Street Analyzer 0

https://www.marketwatch.com/story/oil-steadies-ahead-of-expected-rate-hikes-opec-committee-meeting-11675081999?siteid=yhoof2

Posts navigation

1 2 … 7 »

Featured Companies

CEO Interviews

Zomedica Corp. (NYSE American: ZOM)

November 29, 2022 0

Interview update with Larry Heaton, CEO and President […]

CEO Interviews

Acutus Medical (NASDAQ: AFIB)

November 19, 2022 0

Interview with David Roman, CEO […]

Featured Interviews

Zerify (OTCQB: ZRFY)

November 18, 2022 0

Interview with Mark Kay, CEO and Chairman […]

Featured Interviews

Xortx Therapeutics (CSE: XRX) (NASDAQ: XRTF)

October 25, 2022 0

Interview update with Dr. Allen Davidoff, CEO
[…]

CEO Interviews

Pro-Dex, Inc (NASDAQ: PDEX) CEO Interview Update

October 24, 2022 0

Interview with Rick Van Kirk, CEO […]

News Wire

  • XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease
    February 2, 2023 0
  • Zerify Starts The Year Off Strong
    January 31, 2023 0
  • SCOTTIE RESOURCES INTERCEPTS 34.5 G/T GOLD OVER 4.7 METRES ON BLUEBERRY CONTACT ZONE
    January 26, 2023 0
  • Zomedica to Participate in the Lytham Partners Investor Select Conference
    January 24, 2023 0
  • XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial
    January 23, 2023 0
  • Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies
    January 18, 2023 0
  • SCOTTIE RESOURCES ANNOUNCES BOARD APPOINTMENT OF ELLIE OWENS
    January 17, 2023 0




Follow on Facebook

About Us

The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
Quick links
  • Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
Stay connected
  • Facebook
  • Twitter
Recent Case Study
Biotech

Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

August 12, 2019 Comments Off on Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

About Co-Diagnostics, Inc: Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection […]

Testimonials
Testimonials

Client Testimonials:

June 1, 2020 Comments Off on Client Testimonials:

“What we like most about the wallstreetanalyzer.com was their service consistently brought Marifil Mines Ltd new viewers to our company.  The interviews are high quality, to the point, friendly and enlightening.  We have been using his […]

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com